KALA BIO, Inc. KALA
Set alert
As of Nov 2, 10:45 AM ET
- YTD
- -99.39%
- 1 year
- -99.57%
- Open
- 0.17
- Prev close
- 0.1655
- Mkt cap
- 3.27M
- Vol
- 33.68K
- Avg vol
- 1.51M
- EPS
- -10.71
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1664
- High
- 0.1799
- Forward P/E
- -0.90
- Beta
- -2.14
- Short ratio
- 1.91
- Inst. own
- 48.13%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.42
- 200-d avg
- 6.50
- 1y target
- 15.00
News
1 week ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Pomdoctor (NASDAQ:POM) shares rose 25.6% to $1.47 during Friday's after-market session. The market value of their outstanding shares is at $8.3 million. GeneDx Holdings (NASDAQ:WGS) shares…
3 weeks ago defenseworld.net
KALA BIO, Inc. (NASDAQ:KALA) Stock Short Interest Report for September
KALA BIO, Inc. (NASDAQ: KALA - Get Free Report) was the target of a large growth in short interest in September. As of September 30th, there was short interest totaling 1,358,824 shares, a growth of…
3 weeks ago defenseworld.net
KALA BIO (NASDAQ:KALA) Stock Falls 0.9% – Time to Sell?
KALA BIO, Inc. (NASDAQ: KALA - Get Free Report) shares fell 0.9% during mid-day trading on Friday. The stock traded as low as $0.2860 and last traded at $0.2940. Approximately 285,090 shares traded…
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Elutia (NASDAQ:ELUT) stock moved upwards by 17.2% to $0.94 during Thursday's after-market session. The market value of their outstanding shares is at $34.9 million. Intelligent Bio Solutions…
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Monte Rosa Therapeutics (NASDAQ:GLUE) stock rose 9.7% to $13.09 during Wednesday's after-market session. The company's market cap stands at $1.0 billion. Filana Therapeutics (NASDAQ:FLNA)…
1 month ago benzinga.com
Why FingerMotion Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
FingerMotion jumped 18.1% premarket after agreeing to buy Newbit Technology for $2.3M cash; NewGenIvf led gainers at 187.2%, while Silexion fell 16.6%.
1 month ago benzinga.com
KALA Bio (KALA) Shares Soar 57% After Hours: Here's Why
KALA Bio shares surge after hours after signing an LOI to acquire a nationwide telehealth platform.
1 month ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Silexion Therapeutics (NASDAQ:SLXN) shares rose 26.8% to $0.32 during Tuesday's pre-market session. The company's market cap stands at $1.3 million. Summit Therapeutics (NASDAQ:SMMT) stock…
-
1 month ago benzinga.com
KALA Bio Inks Letter Of Intent To Acquire U.S.-Based Management Services Firm For ~$15M
KALA Bio, Inc. (NASDAQ:KALA) ("KALA" or the "Company") today announced that on September 24, 2026, it signed a non-binding letter of intent ("LOI") for the proposed acquisition of 100% of a
1 month ago newsfilecorp.com
KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception
Proposed Acquisition Valued at Approximately $15 Million Would Add an Established 50-State Telehealth Business, with over 90,000 clients, Focused on Peptides such as GLP-1 Weight Management, Hormone…
1 month ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Prime Medicine (NASDAQ:PRME) shares increased by 13.0% to $3.47 during Thursday's after-market session. The market value of their outstanding shares is at $567.7 million. Onconetix…
1 month ago globenewswire.com
Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
Agreement would expand the companies' genetic testing collaboration beyond ophthalmology to a selected suite of genomic testing products through an additional U.S. reseller channel Agreement would…
1 month ago defenseworld.net
KALA BIO, Inc. (NASDAQ:KALA) Given Consensus Recommendation of “Reduce” by Brokerages
Shares of KALA BIO, Inc. (NASDAQ: KALA - Get Free Report) have received a consensus rating of "Reduce" from the five ratings firms that are currently covering the firm, MarketBeat.com reports. One…
1 month ago globenewswire.com
KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team
Founder of The LSM Group to support KALA's growth across its existing business and potential acquisitions Founder of The LSM Group to support KALA's growth across its existing business and potential…
-
2 months ago benzinga.com
Kala Bio And Virotek Finalizes Definitive Exclusive Distribution And Reseller Agreement And Related Quality, Brand, And Data Protection Agreements
Kala Bio, Inc. (NASDAQ:KALA) ("Kala") and Virotek Inc. ("Virotek") today announced that they have finalized a definitive exclusive distribution and reseller agreement (the "Agreement") and
2 months ago globenewswire.com
Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
Agreement Grants Kala Exclusive U.S. Rights to Market and Distribute Virotek's Ophthalmology Genomic Testing Program Agreement Grants Kala Exclusive U.S. Rights to Market and Distribute Virotek's…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers bioAffinity Technologies (NASDAQ:BIAF) shares rose 43.1% to $6.53 during Tuesday's regular session. The company's market cap stands at $2.7 million. USBC (AMEX:USBC) stock moved upwards by…
2 months ago benzinga.com
Dow Dips Over 300 Points; Medtronic Shares Gain After Upbeat Q1 Earnings
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.58% to 52,876.43 while the NASDAQ…
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers bioAffinity Technologies (NASDAQ:BIAF) shares increased by 68.4% to $7.68 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.7 million. Lakewood-Amedex…
-
2 months ago benzinga.com
Kala Bio Inks Letter Of Intent With Virotek To Discuss Potential Deal To Appoint Kala As Exclusive Distributor, Reseller Of Virotek;s Genetic Testing, Screening Program In U.S. For Ophthalmological Indications
Kala Bio, Inc. (Nasdaq: KALA) ("Kala") and Virotek Inc. ("Virotek"), a CLIA-registered precision health and clinical genomics company, today announced that they have entered into a letter of intent…
2 months ago globenewswire.com
Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
ARLINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Kala Bio, Inc. (Nasdaq: KALA) ("Kala") and Virotek Inc. ("Virotek"), a CLIA-registered precision health and clinical genomics company, today…
-
2 months ago benzinga.com
Kala Bio Q2 EPS $(21.32) Up From $(85.64) YoY, Sales $0.00, Same YoY
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(21.32) per share. This is a 75.11 percent increase over losses of $(85.64) per share from the same period last year. The company reported $0.00…
3 months ago defenseworld.net
KALA BIO (KALA) Expected to Post Earnings on Thursday
KALA BIO (NASDAQ: KALA - Get Free Report) is anticipated to release its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect KALA BIO to post earnings of ($6.00) per share…
-
5 months ago benzinga.com
Kala Bio Q1 EPS $(0.14) Beats $(0.30) Estimate
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.30) by 53.33 percent. This is a 99.8 percent increase over losses of $(70.49)…
5 months ago globenewswire.com
KALA BIO Announces Reverse Stock Split
ARLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) (“KALA BIO” or the “Company”), today announced that it intends to effect a reverse stock split of its common stock,…
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
6 months ago globenewswire.com
Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
ARLINGTON, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) (“KALA” or the “Company”) today celebrated the landmark Executive Order signed by U.S. President Donald J.
6 months ago benzinga.com
Top 3 Health Care Stocks Which Could Blast Off This Quarter
Undervalued companies in health care sector with low RSI values present buying opportunity: PepGen Inc (PEPG), KALA BIO Inc (KALA), Viridian Therapeutics Inc (VRDN)
7 months ago defenseworld.net
KALA BIO (NASDAQ:KALA) vs. Celularity (NASDAQ:CELU) Financial Survey
Celularity (NASDAQ: CELU - Get Free Report) and KALA BIO (NASDAQ: KALA - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses…
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
7 months ago globenewswire.com
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
Engagement will assess KALA's clinical assets, development options, and AI-enabled analytical opportunities, including the MSC Secretome platform Engagement will assess KALA's clinical assets,…
7 months ago globenewswire.com
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
Next-Generation Agentic AI Platform Achieves Live Enterprise Deployment, Delivering Secure, Scalable, Autonomous Research Solutions to Global Biotechnology and Pharmaceutical Organizations…
7 months ago benzinga.com
EXCLUSIVE: Penny Stock Kala Bio Transitions To Revenue Model With AI Platform Launch
The company confirmed that BIRA is now live in client-controlled environments, marking its entry into revenue-generating AI infrastructure.
7 months ago defenseworld.net
KALA BIO, Inc. (NASDAQ:KALA) Receives Consensus Rating of “Hold” from Analysts
KALA BIO, Inc. (NASDAQ: KALA - Get Free Report) has been given a consensus recommendation of "Hold" by the six brokerages that are covering the firm, MarketBeat.com reports. One equities research…
7 months ago globenewswire.com
Red Light Holland Engages Kala Bio's Researgency.AI Platform to Support Clinical Development of Filament's Patented PEX010 Botanical Psilocybin Drug Candidate
AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio's purpose-built agentic AI platform for the biotechnology industry TORONTO…
7 months ago newsfilecorp.com
Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate
AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio's purpose-built agentic AI platform for the biotechnology industry…
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
7 months ago benzinga.com
Highpeak Energy Posts Downbeat Q4 Results, Joins Netskope, Descartes Systems And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures fall 250 points, Highpeak Energy shares drop 7%. Other stocks also down in pre-market trading after reporting earnings.
7 months ago benzinga.com
Highpeak Energy Posts Downbeat Q4 Results, Joins Netskope, Descartes Systems And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures fall 250 points, Highpeak Energy shares drop 7%. Other stocks also down in pre-market trading after reporting earnings.
7 months ago benzinga.com
Crude Oil Gains Over 5%; US Inflation Holds Steady At 2.4%
US stocks mixed, Dow down 300 points. Dow down 0.71%, Nasdaq up 0.21%, S&P 500 down 0.13%. Energy sector up 1.4%, consumer staples down 1.6%. US consumer inflation holds steady in Feb, up 2.4% YoY.…
7 months ago newsfilecorp.com
Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents
Open-source breakthrough demonstrates AI agents can run 100+ experiments overnight-reinforcing the agentic R&D paradigm Researgency.ai is bringing to life sciences with Kala Bio (KALA) Toronto,…
7 months ago benzinga.com
US Stocks Mixed; Dow Falls 300 Points
US stocks traded mixed, with Dow down 0.63% while NASDAQ and S&P 500 rose. Energy shares rose by 0.8% while materials stocks dipped by 1.4%. Campbell's reported worse-than-expected results and…
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
7 months ago globenewswire.com
Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates
Platform Rebrand of Researgency.ai; First Purpose-Built AI Agent for Biotech Expected to Ship Within Two Weeks Platform Rebrand of Researgency.ai; First Purpose-Built AI Agent for Biotech Expected to…
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
10 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
10 months ago benzinga.com
Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket